The Food and Drug Administration announced Tuesday it is investigating a Dutch company that sends abortion-inducing drugs to U.S. women by mail from a pharmacy in India.

The leader of a pro-life group under fire in Texas for how it used state funds said headlines declaring the group incompetent and a failure are part of a “pro-choice, pro-abort smear.”

Doctors in Canada should have permission to euthanize a child who requests it, even if it’s against the parents’ will, a team of pediatricians proposed in a report earlier this month.

A policy proposal written by Carey DeMichelis, Randi Zlotnik Shaul, and Adam Rapoport at Toronto’s Hospital for Sick Children outlines how the hospital would decide which children to euthanize under Canada’s medical assistance in dying (MAID) law.

Pro-lifers cannot be forced to hire, lend money to, or rent to people who advocate for or promote abortions, a federal judge in St. Louis ruled last week. The decision overturned a city ordinance that barred landlords, lending agencies, and employers from discriminating against anyone for their “reproductive health decisions or pregnancy status.” Last year, the Thomas More Society, a pro-life legal group, sued the city on behalf of a number of pro-life groups and businesspeople.

Pro-life leaders praised the U.S. Department of Health and Human Services last week for canceling its contract with a fetal tissue company, but they said the government needs to do more to protect aborted babies from becoming commodities after their deaths.

With buzz cuts and matching outfits, three 4-year-old boys romped around the front of a small conference room—peering into a projector, peeking behind curtains, and cartwheeling on the carpeted floor. Nearby, their mother fielded questions from an audience of about 40 on her experience raising five children, including triplet boys.

In Beijing, where most families have only one child, the idea of having five children is unfathomable.

The Food and Drug Administration is severing its contract with Advanced Bioscience Resources, a company that provided human fetal tissue for research, according to a statement Monday from the Department of Health and Human Services. HHS reviewed the contract and determined it did not include enough assurances that ABR meets tissue procurement standards.